Cargando…

Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice

This study aimed to analyze the effects and potential mechanisms of pioglitazone on triglyceride and cholesterol metabolism in obese diabetic KKAy mice. Pioglitazone was orally administered to KKAy mice over 30 days. Compared to C57BL/6J mice, KKAy mice developed obvious insulin resistance, hepatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jun, Huan, Yi, Jiang, Qian, Sun, Su-juan, Jia, Chun-ming, Shen, Zhu-fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988943/ https://www.ncbi.nlm.nih.gov/pubmed/24799887 http://dx.doi.org/10.1155/2014/538183

Ejemplares similares

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023)

Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway
por: Zhang, Xiao-lin, et al.
Publicado: (2019)

Saikokeishikankyoto extract alleviates muscle atrophy in KKAy mice
por: Ou, Yanglan, et al.
Publicado: (2022)

Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet
por: Ikarashi, Nobutomo, et al.
Publicado: (2011)

Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
por: Zhu, Wei, et al.
Publicado: (2014)

Protamine zinc insulin combined with sodium selenite improves glycometabolism in the diabetic KKAy mice
por: Lu, Juan, et al.
Publicado: (2016)

Perilla Oil Supplementation Improves Hypertriglyceridemia and Gut Dysbiosis in Diabetic KKAy Mice
por: Wang, Feng, et al.
Publicado: (2018)

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
por: Cao, Hui, et al.
Publicado: (2020)

Voglibose Regulates the Secretion of GLP-1 Accompanied by Amelioration of Ileal Inflammatory Damage and Endoplasmic Reticulum Stress in Diabetic KKAy Mice
por: Fu, Yaxin, et al.
Publicado: (2022)

The albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice
por: Li, Caina, et al.
Publicado: (2017)

Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
por: Liu, Quan, et al.
Publicado: (2021)

Antidiabetic Activity of Polysaccharides from Tuberous Root of Liriope spicata var. prolifera in KKAy Mice
por: Liu, Yihui, et al.
Publicado: (2013)

Proteomic Profile in Glomeruli of Type-2 Diabetic KKAy Mice using 2-Dimensional Differential Gel Electrophoresis
por: Liu, Xiaodan, et al.
Publicado: (2014)

Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice
por: Zhu, XinWang, et al.
Publicado: (2016)

Angelica polysaccharides relieve blood glucose levels in diabetic KKAy mice possibly by modulating gut microbiota: an integrated gut microbiota and metabolism analysis
por: Tang, Xiaolong, et al.
Publicado: (2023)

Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
por: Clark, M., et al.
Publicado: (2013)

Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice
por: Jia, Chunming, et al.
Publicado: (2015)

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice
por: Yang, Guannan, et al.
Publicado: (2017)

Anti-Diabetic Effects of Jiang Tang Xiao Ke Granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice
por: Yu, Na, et al.
Publicado: (2017)

Liraglutide Exerts Antidiabetic Effect via PTP1B and PI3K/Akt2 Signaling Pathway in Skeletal Muscle of KKAy Mice
por: Ji, Wenjun, et al.
Publicado: (2014)

Chromium–Insulin Reduces Insulin Clearance and Enhances Insulin Signaling by Suppressing Hepatic Insulin-Degrading Enzyme and Proteasome Protein Expression in KKAy Mice
por: Wang, Zhong Q., et al.
Publicado: (2014)

Evaluation of Acute Toxicity of Pioglitazone in Mice
por: Chinnam, Pushpalatha, et al.
Publicado: (2012)

LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
por: Dong, Ziqi, et al.
Publicado: (2018)

Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice
por: Brannian, John D, et al.
Publicado: (2008)

Effects of Pioglitazone Mediated Activation of PPAR-γ on CIDEC and Obesity Related Changes in Mice
por: Shamsi, Bilal Haider, et al.
Publicado: (2014)

The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms
por: Xu, Bilin, et al.
Publicado: (2017)

Data in support of fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice
por: Luo, Du-Qiang, et al.
Publicado: (2015)

Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice
por: Wei, Xiuqing, et al.
Publicado: (2014)

Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes
por: Ilyas, Umair, et al.
Publicado: (2022)

Toxicological evaluation of subchronic use of pioglitazone in mice
por: Elshama, Said Said, et al.
Publicado: (2016)

Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist
por: Kanda, Yukiko, et al.
Publicado: (2010)

Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism
por: Veleba, Jiri, et al.
Publicado: (2015)

Evaluating the antidiabetic effects of Chinese herbal medicine: Xiao-Ke-An in 3T3-L1 cells and KKAy mice using both conventional and holistic omics approaches
por: Yang, Zhenzhong, et al.
Publicado: (2015)

Therapeutic effect and potential mechanism of pioglitazone in rats with severe acute pancreatitis
por: Hai, Wang, et al.
Publicado: (2017)

Serum Levels of Free Fatty Acids in Obese Mice and Their Associations with Routine Lipid Profiles
por: Sun, Shun Yu, et al.
Publicado: (2022)

Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling
por: Gao, Hongli, et al.
Publicado: (2017)

Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats
por: Lamontagne, Julien, et al.
Publicado: (2013)

Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
por: Wang, Yao, et al.
Publicado: (2017)

Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
por: Ferrara, Assiamira, et al.
Publicado: (2011)

Pioglitazone: Indian perspective
por: Shukla, Rishi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l7d69fpbqnsbsfm9e90q8ojt6g